Get Broad Spectrum Antivirals to Human Trials

0 have signed. Let’s get to 5,000!


I am a chemical and biological engineer who has been following the health crisis unfolding with covid-19 or the novel corona virus which has been spread all over the world from China. Many Americans are shocked that health professionals have so little they can do for patients infected with the corona virus because antibiotics have no affect on the infection because antibiotics only kill bacteria. Doctors do not currently have the tools to treat most viral infections currently, but that is likely the fault of drug companies who have failed to bring products to market. Currently, there are more 30 broad-spectrum antivirals that have been developed [1], and none have been allowed for human trials in the US, at least until now. Last week, human use began of a broad spectrum antiviral called Remdesivir for patients infected with the corona virus who are seriously ill under compassionate use.[2] The only infected patient treated with Remdesivir  drastically improved by the next day and was later released, but this is far from a large enough study to determine either effectiveness of the drug or safety. [3] This is where the problem is. Some antivirals have been around for more than a decade with no major drug companies willing to do the research to bring them to human trials before now out of desperation. Broad spectrum antivirals are essentially the penicillin for viruses. Rather than attacking a specific virus, they take advantage of an inherent characteristic of that virus's life cycle such as transcription of RNA. The develop of this new class of drugs would mean more than just saving mankind from the next pandemic (as if that isn't enough). It would mean cures for viral diseases already devastating the world such as HIV. What I am suggesting to you is the possibility of a world where you could go to your doctor on the same day you contract the common cold and never miss a day of work. (Some people may not appreciate that.) That world is not science fiction anymore if the drugs already developed live up to their hype. With only 1 in 10 of drugs brought to human trials eventually becoming a product [4] it is understandable for a pharmaceutical company to be afraid to venture into a new field of medicine, but the benefits greatly outweigh the cost. We must start to demand that drug companies be more proactive about this. Write emails to pharmaceutical companies. Call your senator to tell him or her to sponsor a bill. Now is the time to prevent the NEXT Pandemic

[1]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440912/

[2]
https://www.cnn.com/2020/02/26/us/coronavirus-us-american-treatment-trial/index.html

[3]
https://www.nejm.org/doi/10.1056/NEJMoa2001191

[4]
https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf